v3-MedicationObservationType
type: ValueSet
node role: treeRoot
id:
  v: v3-MedicationObservationType
language:
  v: en
text:
  status:
    v: extensions
  div: Generated Narrative: ValueSet v3-MedicationObservationType Language: en Include these codes as defined in http://terminology.hl7.org/CodeSystem/v3-ActCode version ?9.0.0 Code Display Definition REP_HALF_LIFE representative half-life **Description:**This observation represents an 'average' or 'expected' half-life typical of the product. SPLCOATING coating **Definition:** A characteristic of an oral solid dosage form of a medicinal product, indicating whether it has one or more coatings such as sugar coating, film coating, or enteric coating. Only coatings to the external surface or the dosage form should be considered (for example, coatings to individual pellets or granules inside a capsule or tablet are excluded from consideration). **Constraints:** The Observation.value must be a Boolean (BL) with true for the presence or false for the absence of one or more coatings on a solid dosage form. SPLCOLOR color **Definition:** A characteristic of an oral solid dosage form of a medicinal product, specifying the color or colors that most predominantly define the appearance of the dose form. SPLCOLOR is not an FDA specification for the actual color of solid dosage forms or the names of colors that can appear in labeling. **Constraints:** The Observation.value must be a single coded value or a list of multiple coded values, specifying one or more distinct colors that approximate of the color(s) of distinct areas of the solid dosage form, such as the different sides of a tablet or one-part capsule, or the different halves of a two-part capsule. Bands on banded capsules, regardless of the color, are not considered when assigning an SPLCOLOR. Imprints on the dosage form, regardless of their color are not considered when assigning an SPLCOLOR. If more than one color exists on a particular side or half, then the most predominant color on that side or half is recorded. If the gelatin capsule shell is colorless and transparent, use the predominant color of the contents that appear…
url:
  v: http://terminology.hl7.org/ValueSet/v3-MedicationObservationType
identifier:
  system:
    v: urn:ietf:rfc:3986
  value:
    v: urn:oid:2.16.840.1.113883.1.11.19751
version:
  v: 3.0.0
name:
  v: MedicationObservationType
title:
  v: MedicationObservationType
status:
  v: active
experimental:
  v: false
date:
  v: 2014-03-26
publisher:
  v: Health Level Seven International
contact:
  telecom:
    system:
      v: url
    value:
      v: http://hl7.org
  telecom:
    system:
      v: email
description:
  v: ***No description***
copyright:
  v: This material derives from the HL7 Terminology THO. THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html
compose:
  include:
    system:
      v: http://terminology.hl7.org/CodeSystem/v3-ActCode
    concept:
      code:
        v: REP_HALF_LIFE
    concept:
      code:
        v: SPLCOATING
    concept:
      code:
        v: SPLCOLOR
    concept:
      code:
        v: SPLIMAGE
    concept:
      code:
        v: SPLIMPRINT
    concept:
      code:
        v: SPLSCORING
    concept:
      code:
        v: SPLSHAPE
    concept:
      code:
        v: SPLSIZE
    concept:
      code:
        v: SPLSYMBOL